References
- Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017;873–881. doi:https://doi.org/10.1016/S1473-3099(17)30243-8.
- Williamson PR. The relentless march of cryptococcal meningitis. Lancet Infect Dis. 2017;790–791. doi:https://doi.org/10.16/S1473-3099(17)30245-1.
- Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017;13:13–24. doi:https://doi.org/10.38/nrneurol.2016.167.
- Falci DR, da Rosa FB, Hematological toxicities associated with amphotericin B formulations. Leuk Lymphoma. 2015;56:2889–94. doi:https://doi.org/10.9/10428194.2015.1010080.
- Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Pikounis VB, Bouffard AF, Dropinski JF, Rosen H, et al. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother. 1997;41:2333–8.
- Feldmesser M, Kress Y, Mednick A, Casadevall A. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J Infect Dis 2000;182:1791–5. doi:https://doi.org/10.1086/317614.
- Smith KD, Achan B, Hullsiek KH, McDonald TR, Okagaki LH, Alhadab AA, Akampurira A, Rhein JR, Meya DB, Boulware DR, et al. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda. Antimicrob Agents Chemotherr. 2015;59:7197–204. doi:https://doi.org/10.1128/AAC.01299-15.
- Pan W, Khayhan K, Hagen F, Wahyuningsih R, Chakrabarti A, Chowdhary A, Ikeda R, Taj-Aldeen SJ, Khan Z, Imran D, et al. Resistance of Asian Cryptococcus neoformans serotype A is confined to few microsatellite genotypes. PloS one. 2012;7:e32868. doi:https://doi.org/10.1371/journal.pone.0032868.
- Kozubowski L, Lee SC, Heitman J. Signalling pathways in the pathogenesis of Cryptococcus. Cell Microbiol. 2009;11:370–80. doi:https://doi.org/10.1111/j.1462-5822.2008.01273.x.
- McCotter SW, Horianopoulos LC, Kronstad JW. Regulation of the fungal secretome. Current genetics. 2016;62:533–45. doi:https://doi.org/10.1007/s00294-016-0578-2.
- Rodrigues ML, Djordjevic JT. Unravelling secretion in Cryptococcus neoformans: more than one way to skin a cat. Mycopathologia. 2012;173:407–18. doi:https://doi.org/10.1007/s11046-011-9468-9.
- Geddes JM, Croll D, Caza M, Stoynov N, Foster LJ, Kronstad JW. Secretome profiling of Cryptococcus neoformans reveals regulation of a subset of virulence-associated proteins and potential biomarkers by protein kinase A. BMC Microbiol. 2015;15:206. doi:https://doi.org/10.1186/s12866-015-0532-3.
- Waterman SR, Hacham M, Panepinto J, Hu G, Shin S, Williamson PR. Cell wall targeting of laccase of Cryptococcus neoformans during infection of mice. Infect Immun. 2007;75:714–22. doi:https://doi.org/10.1128/IAI.01351-06.
- Siafakas AR, Sorrell TC, Wright LC, Wilson C, Larsen M, Boadle R, Williamson PR, Djordjevic JT. Cell wall-linked cryptococcal phospholipase B1 is a source of secreted enzyme and a determinant of cell wall integrity. J Biol Chem. 2007;282:37508–14. doi:https://doi.org/10.1074/jbc.M707913200.
- Yoneda A, Doering TL. A eukaryotic capsular polysaccharide is synthesized intracellularly and secreted via exocytosis. Mol Biol Cell. 2006;17:5131–40. doi:https://doi.org/10.1091/mbc.E06-08-0701.
- Rodrigues ML, Nakayasu ES, Oliveira DL, Nimrichter L, Nosanchuk JD, Almeida IC, Casadevall A. Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence. Eukaryotic cell. 2008;7:58–67. doi:https://doi.org/10.1128/EC.00370-07.
- Reese AJ, Doering TL. Cell wall alpha-1,3-glucan is required to anchor the Cryptococcus neoformans capsule. Eukaryot Cell. 2003;50:1401–9. doi:https://doi.org/10.1046/j.1365-2958.2003.03780.x.
- Reese AJ, Yoneda A, Breger JA, Beauvais A, Liu H, Griffith CL, Bose I, Kim MJ, Skau C, Yang S, et al. Loss of cell wall alpha(1-3) glucan affects Cryptococcus neoformans from ultrastructure to virulence. Mol Microbiol. 2007;63:1385–98. doi:https://doi.org/10.1111/j.1365-2958.2006.05551.x.
- Levitz SM. Innate recognition of fungal cell walls. PLoS Pathog. 2010;6:e1000758. doi:https://doi.org/10.1371/journal.ppat.1000758.
- Lev S, Desmarini D, Li C, Chayakulkeeree M, Traven A, Sorrell TC, Djordjevic JT. Phospholipase C of Cryptococcus neoformans regulates homeostasis and virulence by providing inositol trisphosphate as a substrate for Arg1 kinase. Infect Immun. 2013;81:1245–55. doi:https://doi.org/10.1128/IAI.01421-12.
- Wilson MS, Livermore TM, Saiardi A. Inositol pyrophosphates: between signalling and metabolism. Biochem J. 2013;452:369–79. doi:https://doi.org/10.1042/BJ20130118.
- Shears SB. Inositol pyrophosphates: why so many phosphates? Adv Biol Regul. 2015;57:203–16. doi:https://doi.org/10.1016/j.jbior.2014.09.015.
- Lev S, Li C, Desmarini D, Saiardi A, Fewings NL, Schibeci SD, Sharma R, Sorrell TC, Djordjevic JT. Fungal Inositol Pyrophosphate IP7 Is Crucial for Metabolic Adaptation to the Host Environment and Pathogenicity. mBio. 2015;6:e00531–15. doi:https://doi.org/10.1128/mBio.00531-15.
- Li C, Lev S, Saiardi A, Desmarini D, Sorrell TC, Djordjevic JT. Identification of a major IP5 kinase in Cryptococcus neoformans confirms that PP-IP5/IP7, not IP6, is essential for virulence. Sci Rep. 2016;6:23927. doi:https://doi.org/10.1038/srep23927.
- Dubois E, Messenguy F. Pleiotropic function of ArgRIIIp (Arg82p), one of the regulators of arginine metabolism in Saccharomyces cerevisiae. Role in expression of cell-type-specific genes. Mol Gen Genet: MGG. 1994;243:315–24.
- Dubois E, Scherens B, Vierendeels F, Ho MM, Messenguy F, Shears SB. In Saccharomyces cerevisiae, the inositol polyphosphate kinase activity of Kcs1p is required for resistance to salt stress, cell wall integrity, and vacuolar morphogenesis. J Biol Chem. 2002;277:23755–63. doi:https://doi.org/10.1074/jbc.M202206200.
- Seeds AM, Bastidas RJ, York JD. Molecular definition of a novel inositol polyphosphate metabolic pathway initiated by inositol 1,4,5-trisphosphate 3-kinase activity in Saccharomyces cerevisiae. J Biol Chem. 2005;280:27654–61. doi:https://doi.org/10.1074/jbc.M505089200.
- Saiardi A, Nagata E, Luo HR, Sawa A, Luo X, Snowman AM, Snyder SH. Mammalian inositol polyphosphate multikinase synthesizes inositol 1,4,5-trisphosphate and an inositol pyrophosphate. Proc Natl Acad Sci U S A. 2001;98:2306–11. doi:https://doi.org/10.1073/pnas.041614598.
- Cox GM, McDade HC, Chen SC, Tucker SC, Gottfredsson M, Wright LC, Sorrell TC, Leidich SD, Casadevall A, Ghannoum MA, et al. Extracellular phospholipase activity is a virulence factor for Cryptococcus neoformans. Mol Microbiol. 2001;39:166–75. doi:https://doi.org/10.1046/j.1365-2958.2001.02236.x.
- Turner KM, Wright LC, Sorrell TC, Djordjevic JT. N-linked glycosylation sites affect secretion of cryptococcal phospholipase B1, irrespective of glycosylphosphatidylinositol anchoring. Biochim Biophys Acta. 2006;1760:1569–79. doi:https://doi.org/10.1016/j.bbagen.2006.07.002.
- Chayakulkeeree M, Johnston SA, Oei JB, Lev S, Williamson PR, Wilson CF, Zuo X, Leal AL, Vainstein MH, Meyer W, et al. SEC14 is a specific requirement for secretion of phospholipase B1 and pathogenicity of Cryptococcus neoformans. Mol Microbiol. 2011;80:1088–101. doi:https://doi.org/10.1111/j.1365-2958.2011.07632.x.
- Lev S, Crossett B, Cha SY, Desmarini D, Li C, Chayakulkeeree M, Wilson CF, Williamson PR, Sorrell TC, Djordjevic JT. Identification of Aph1, a phosphate-regulated, secreted, and vacuolar acid phosphatase in Cryptococcus neoformans. mBio. 2014;5:e01649–14. doi:https://doi.org/10.1128/mBio.01649-14.
- Djordjevic JT, Del Poeta M, Sorrell TC, Turner KM, Wright LC. Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. Biochem J. 2005;389:803–12. doi:https://doi.org/10.1042/BJ20050063.
- Chayakulkeeree M, Sorrell TC, Siafakas AR, Wilson CF, Pantarat N, Gerik KJ, Boadle R, Djordjevic JT. Role and mechanism of phosphatidylinositol-specific phospholipase C in survival and virulence of Cryptococcus neoformans. Mol Microbiol. 2008;69:809–26.
- Chen SC, Wright LC, Golding JC, Sorrell TC. Purification and characterization of secretory phospholipase B, lysophospholipase and lysophospholipase/transacylase from a virulent strain of the pathogenic fungus Cryptococcus neoformans. Biochem J. 2000;347:431–9. doi:https://doi.org/10.1042/bj3470431 https://doi.org/10.1042/0264-6021:3470431.
- Lev S, Kaufman-Francis K, Desmarini D, Juillard PG, Li C, Stifter SA, Feng CG, Sorrell TC, Grau GE, Bahn YS, et al. Pho4 Is Essential for Dissemination of Cryptococcus neoformans to the Host Brain by Promoting Phosphate Uptake and Growth at Alkaline pH. mSphere. 2017;2. doi:https://doi.org/10.1128/mSphere.00381-16.
- Osterholzer JJ, Milam JE, Chen GH, Toews GB, Huffnagle GB, Olszewski MA. Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans. Infect Immun. 2009;77:3749–58. doi:https://doi.org/10.1128/IAI.00454-09.
- Feldmesser M, Kress Y, Novikoff P, Casadevall A. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect Immun. 2000;68:4225–37. doi:https://doi.org/10.1128/IAI.68.7.4225-4237.2000.
- Mayr GW, Windhorst S, Hillemeier K. Antiproliferative plant and synthetic polyphenolics are specific inhibitors of vertebrate inositol-1,4,5-trisphosphate 3-kinases and inositol polyphosphate multikinase. J Biol Chem. 2005;280:13229–40. doi:https://doi.org/10.1074/jbc.M500545200.
- Voglmaier SM, Bembenek ME, Kaplin AI, Dorman G, Olszewski JD, Prestwich GD, Snyder SH. Purified inositol hexakisphosphate kinase is an ATP synthase: diphosphoinositol pentakisphosphate as a high-energy phosphate donor. Proc Natl Acad Sci U S A. 1996;93:4305–10. doi:https://doi.org/10.1073/pnas.93.9.4305.
- Saiardi A, Erdjument-Bromage H, Snowman AM, Tempst P, Snyder SH. Synthesis of diphosphoinositol pentakisphosphate by a newly identified family of higher inositol polyphosphate kinases. Curr Biol. 1999;9:1323–6. doi:https://doi.org/10.1016/S0960-9822(00)80055-X.
- Szijgyarto Z, Garedew A, Azevedo C, Saiardi A. Influence of inositol pyrophosphates on cellular energy dynamics. Science. 2011;334:802–5. doi:https://doi.org/10.1126/science.1211908.
- Cross CE, Bancroft GJ. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun. 1995;63:2604–11.
- Popolo L, Gilardelli D, Bonfante P, Vai M. Increase in chitin as an essential response to defects in assembly of cell wall polymers in the ggp1delta mutant of Saccharomyces cerevisiae. J Bacteriol. 1997;179:463–9. doi:https://doi.org/10.1128/jb.179.2.463-469.1997.
- Terashima H, Yabuki N, Arisawa M, Hamada K, Kitada K. Up-regulation of genes encoding glycosylphosphatidylinositol (GPI)-attached proteins in response to cell wall damage caused by disruption of FKS1 in Saccharomyces cerevisiae. Mol Gen Genet: MGG. 2000;264:64–74. doi:https://doi.org/10.1007/s004380000285.
- Lagorce A, Le Berre-Anton V, Aguilar-Uscanga B, Martin-Yken H, Dagkessamanskaia A, Francois J. Involvement of GFA1, which encodes glutamine-fructose-6-phosphate amidotransferase, in the activation of the chitin synthesis pathway in response to cell-wall defects in Saccharomyces cerevisiae. Eur J Biochem / FEBS. 2002;269:1697–707. doi:https://doi.org/10.1046/j.1432-1327.2002.02814.x.
- Lemmon MA, Ferguson KM, O'Brien R, Sigler PB, Schlessinger J. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc Natl Acad Sci U S A. 1995;92:10472–6. doi:https://doi.org/10.1073/pnas.92.23.10472.
- Takeuchi H, Kanematsu T, Misumi Y, Sakane F, Konishi H, Kikkawa U, Watanabe Y, Katan M, Hirata M. Distinct specificity in the binding of inositol phosphates by pleckstrin homology domains of pleckstrin, RAC-protein kinase, diacylglycerol kinase and a new 130 kDa protein. Biochim Biophys Acta. 1997;1359:275–85. doi:https://doi.org/10.1016/S0167-4889(97)00109-2.
- Millard CJ, Watson PJ, Celardo I, Gordiyenko Y, Cowley SM, Robinson CV, Fairall L, Schwabe JW. Class I HDACs share a common mechanism of regulation by inositol phosphates. Mol Cell. 2013;51:57–67. doi:https://doi.org/10.1016/j.molcel.2013.05.020.
- Watson PJ, Fairall L, Santos GM, Schwabe JW. Structure of HDAC3 bound to co-repressor and inositol tetraphosphate. Nature. 2012;481:335–40.
- Fukuda M, Kojima T, Kabayama H, Mikoshiba K. Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity. J Biol Chem. 1996;271:30303–6. doi:https://doi.org/10.1074/jbc.271.48.30303.
- Komander D, Fairservice A, Deak M, Kular GS, Prescott AR, Peter Downes C, Safrany ST, Alessi DR, van Aalten DM. Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphates. EMBO J. 2004;23:3918–28. doi:https://doi.org/10.1038/sj.emboj.7600379.
- Losito O, Szijgyarto Z, Resnick AC, Saiardi A. Inositol pyrophosphates and their unique metabolic complexity: analysis by gel electrophoresis. PloS one. 2009;4:e5580. doi:https://doi.org/10.1371/journal.pone.0005580.
- Siafakas AR, Wright LC, Sorrell TC, Djordjevic JT. Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. Eukaryot Cell. 2006;5:488–98. doi:https://doi.org/10.1128/EC.5.3.488-498.2006.
- Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–8. doi:https://doi.org/10.1006/meth.2001.1262.